Clinical Trials Directory

Trials / Completed

CompletedNCT00966173

International Melanoma Algorithm Training Study - IMATS

An International, Multicenter, Prospective, Non-controlled, Non-randomised, Clinical Study to Collect Impedance Data of Potentially Malignant Pigmented Nevi and Histological Diagnoses

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,800 (estimated)
Sponsor
SciBase AB · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is an international, multicenter, prospective, non controlled, non randomized, clinical study to collect electrical impedance data of potentially malignant pigmented nevi and histological diagnoses (International Melanoma Algorithm Training Study \[IMATS\]). The study objective is to collect data for training and optimization of an algorithm that can classify skin lesions using electrical impedance, i.e., to identify malignant melanomas.

Conditions

Interventions

TypeNameDescription
DEVICESciBase III Electrical Impedance SpectrometerFollowing enrollment, patients will undergo measurements with SciBase III Electrical Impedance Spectrometer. Electrical impedance of the skin will be measured with a microinvasive spiked probe.

Timeline

Start date
2005-12-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2009-08-26
Last updated
2010-08-11

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT00966173. Inclusion in this directory is not an endorsement.

International Melanoma Algorithm Training Study - IMATS (NCT00966173) · Clinical Trials Directory